Swiss Life Asset Management »

Kalvista Pharmaceuticals shares owned by Swiss Life Asset Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Swiss Life Asset Management from 13F filings

Historical chart of Swiss Life Asset Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Swiss Life Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Swiss Life Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 22k 63.10

More positions owned by Swiss Life Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Verizon Communications (VZ)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Altria (MO)
Pfizer (PFE)
Visa Com Cl A (V)

View all positions for Swiss Life Asset Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
State Street Corporation
Vestal Point Capital
Vanguard Capital Management
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals